This interactive tool helps investigators, sponsors, regulators, and others in designing a pregnancy testing plan for a clinical trial by estimating the likelihood of a woman enrolling in the study while pregnant, or becoming pregnant during the study.
By calculating the probability of pregnant participants, the tool provides a quantitative method to assess the advantages (reduced risk of embryo/fetal exposure) versus burdens (participant burden, study team workload, costs, etc.) of a pregnancy testing plan, as recommended by the CTTI Pregnancy Testing Project. Users can change the values of certain key variables to compare the probability of pregnant participants under different assumptions. Click here for more information on the outcomes predictor's calculations.
Note: The tool does NOT provide explicit guidance on the optimal pregnancy testing plan for a clinical trial. The level of acceptable risk of unintended embryo/fetal exposure to a trial intervention is based on judgment by investigators, sponsors, and regulators. The tool provides estimates of risk for each pregnancy testing plan, and it is up to users to determine which plan is acceptable.
Total number of females of reproductive potential | ??? |
---|---|
Total undiagnosed pregnancies within 1 month prior to screening | |
With no use of contraception | ??? |
With "population" distribution of contraceptive methods info | ??? |
With highly effective methods only info | ??? |
Total pregnancies during the study | |
With no use of contraception | ??? |
With "population" distribution of contraceptive methods info | ??? |
With highly effective methods only | ??? |
Note: The model does not adjust for the high rate of early spontaneous pregnancy loss. A substantial proportion of pregnancies detected by testing would end in early miscarriage 1 , meaning fewer pregnancies would actually be at risk for exposure to study interventions.
Detected Pregnancy info | "Undetected" pregnancy | False positive / indeterminate info | True negative | ||
---|---|---|---|---|---|
hCG below threshold info | Test performed prior to implantation info | ||||
Initial Screening (???) info | |||||
Serum | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 20 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 25 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 50 mIU | ??? | ??? | ??? | ??? | ??? |
Monthly Testing During ??? Months of Study (???) info | |||||
Serum | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 20 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 25 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 50 mIU | ??? | ??? | ??? | ??? | ??? |
Detected pregnancy | "Undetected" pregnancy | False positive / indeterminate | True negative | ||
---|---|---|---|---|---|
hCG below threshold | Test performed prior to implantation | ||||
Initial Screening (???) info | |||||
Serum | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 20 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 25 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 50 mIU | ??? | ??? | ??? | ??? | ??? |
Monthly Testing During ??? Months of Study (???) info | |||||
Serum | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 20 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 25 mIU | ??? | ??? | ??? | ??? | ??? |
Urine, threshold 50 mIU | ??? | ??? | ??? | ??? | ??? |
User Input: The tool requires users to estimate three characteristics of the proposed study:
Based on the number of women at risk for pregnancy, their age distribution, and the study duration, the model estimates the number of expected test results for different thresholds of hCG detectability. Note that some numbers may be less than 1.0 for relatively small studies with few women at risk.
Detected pregnancies: Women with pregnancies and hCG levels above the threshold of a given hCG test.
Undetected pregnancies, hCG below threshold: Women with pregnancies and hCG levels below the threshold of a given hCG test.
Undetected pregnancies, test performed prior to implantation: Women who will become pregnant in a given month but whose randomly timed pregnancy test is performed in the 3 weeks prior to implantation.
False positive/indeterminate: Non-pregnant women (typically perimenopausal women) with very low levels of pituitary hCG.